Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States.

ABSTRACT:

Background

Ensuring equal access to antiretroviral therapy (henceforth therapy) should alleviate disparities in health outcomes among persons infected with human immunodeficiency virus (HIV). However, evidence supporting the persistence of disparities in survival following therapy initiation is mixed.

Methods

Patients initiating therapy in eight academic medical centers in the Centers for AIDS Research Network of Integrated Clinical Systems between 1 January 1998 and 30 December 2011. Patients (n = 10 017) were followed from therapy initiation until death from any cause, administrative censoring at 10 years after therapy initiation or the end of follow-up on 31 December 2011. The 10-year risk of all-cause mortality was calculated from standardized Kaplan-Meier survival curve

SUBMITTER: Lesko CR 

PROVIDER: S-EPMC4447784 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature